Basil Rigas
Affiliations: | Chemistry | Stony Brook University, Stony Brook, NY, United States |
Area:
Polymer Chemistry, Pharmaceutical ChemistryWebsite:
https://medicine.stonybrookmedicine.edu/medicine/cancer_prevention/rigas_lab_people/rigasGoogle:
"Basil Rigas"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Stancy J. Joseph | grad student | 2010 | SUNY Stony Brook |
| Onika T. Murray | grad student | 2012 | SUNY Stony Brook |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luo D, DiGiovanni MG, Wei R, et al. (2019) Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine. Carcinogenesis |
| Luo D, Fraga-Lauhirat M, Millings J, et al. (2019) Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. Carcinogenesis |
| Kathawala RJ, Kudelka A, Rigas B. (2018) Correction: The Chemoprevention of Ovarian Cancer: the Need and the Options. Current Pharmacology Reports. 4: 414 |
| Kathawala RJ, Kudelka A, Rigas B. (2018) The Chemoprevention of Ovarian Cancer: the Need and the Options. Current Pharmacology Reports. 4: 250-260 |
| Mattheolabakis G, Wang R, Rigas B, et al. (2018) [Corrigendum] Phospho‑valproic acid inhibits pancreatic cancer growth in mice: Enhanced efficacy by its formulation in poly‑(L)‑lactic acid‑poly(ethylene glycol) nanoparticles. International Journal of Oncology |
| Honkanen RA, Huang L, Xie G, et al. (2018) Phosphosulindac is efficacious in an improved concanavalin A-based rabbit model of chronic dry eye disease. Translational Research : the Journal of Laboratory and Clinical Medicine |
| Mattheolabakis G, Wang R, Rigas B, et al. (2017) Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles. International Journal of Oncology |
| Mattheolabakis G, Papayannis I, Yang J, et al. (2016) Phospho-aspirin (MDC-22) prevents pancreatic carcinogenesis in mice. Cancer Prevention Research (Philadelphia, Pa.) |
| Bartels LE, Mattheolabakis G, Vaeth BM, et al. (2016) The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1. Carcinogenesis |
| Tsioulias GJ, Go MF, Rigas B. (2015) NSAIDs and Colorectal Cancer Control: Promise and Challenges. Current Pharmacology Reports. 1: 295-301 |